Cargando…
Obinutuzumab in connective tissue diseases after former rituximab-non-response: a case series
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995802/ https://www.ncbi.nlm.nih.gov/pubmed/35027400 http://dx.doi.org/10.1136/annrheumdis-2021-221756 |
| _version_ | 1784684360874590208 |
|---|---|
| author | Kvacskay, Peter Merkt, Wolfgang Günther, Janine Blank, Norbert Lorenz, Hanns-Martin |
| author_facet | Kvacskay, Peter Merkt, Wolfgang Günther, Janine Blank, Norbert Lorenz, Hanns-Martin |
| author_sort | Kvacskay, Peter |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8995802 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | BMJ Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89958022022-04-27 Obinutuzumab in connective tissue diseases after former rituximab-non-response: a case series Kvacskay, Peter Merkt, Wolfgang Günther, Janine Blank, Norbert Lorenz, Hanns-Martin Ann Rheum Dis Letter BMJ Publishing Group 2022-05 2022-01-13 /pmc/articles/PMC8995802/ /pubmed/35027400 http://dx.doi.org/10.1136/annrheumdis-2021-221756 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
| spellingShingle | Letter Kvacskay, Peter Merkt, Wolfgang Günther, Janine Blank, Norbert Lorenz, Hanns-Martin Obinutuzumab in connective tissue diseases after former rituximab-non-response: a case series |
| title | Obinutuzumab in connective tissue diseases after former rituximab-non-response: a case series |
| title_full | Obinutuzumab in connective tissue diseases after former rituximab-non-response: a case series |
| title_fullStr | Obinutuzumab in connective tissue diseases after former rituximab-non-response: a case series |
| title_full_unstemmed | Obinutuzumab in connective tissue diseases after former rituximab-non-response: a case series |
| title_short | Obinutuzumab in connective tissue diseases after former rituximab-non-response: a case series |
| title_sort | obinutuzumab in connective tissue diseases after former rituximab-non-response: a case series |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995802/ https://www.ncbi.nlm.nih.gov/pubmed/35027400 http://dx.doi.org/10.1136/annrheumdis-2021-221756 |
| work_keys_str_mv | AT kvacskaypeter obinutuzumabinconnectivetissuediseasesafterformerrituximabnonresponseacaseseries AT merktwolfgang obinutuzumabinconnectivetissuediseasesafterformerrituximabnonresponseacaseseries AT guntherjanine obinutuzumabinconnectivetissuediseasesafterformerrituximabnonresponseacaseseries AT blanknorbert obinutuzumabinconnectivetissuediseasesafterformerrituximabnonresponseacaseseries AT lorenzhannsmartin obinutuzumabinconnectivetissuediseasesafterformerrituximabnonresponseacaseseries |